World-Leading Pharmaceuticals Company Secures Global Manufacturing Assets Using Breakthrough ARIA Cybersecurity Solution
- None.
- None.
Insights
The deployment of ARIA Cybersecurity's AZT PROTECT by a leading pharmaceutical company signifies a crucial step forward in the fortification of critical infrastructure against cyber threats. In the context of cybersecurity, operational technology (OT) refers to hardware and software that monitors or controls equipment, assets and processes. The protection of OT is paramount as it directly impacts the safety and efficiency of physical processes.
The integration of AZT PROTECT, a solution tailored for OT environments, addresses the unique vulnerabilities these systems face, such as the need for uninterrupted operation and the difficulty of applying regular updates and patches. The pharmaceutical sector's reliance on OT for manufacturing means that any disruption due to cyberattacks can have severe consequences, not only financially but also on public health, as it could impede the production and distribution of medicines.
By choosing a solution that neutralizes attacks in real-time and reduces the need for production downtime, this pharmaceutical giant is not only safeguarding its assets but also ensuring continuity in operations. This move may set a precedent in the industry, potentially leading to a new standard in cybersecurity practices for OT environments.
The announcement of a multi-million dollar cybersecurity deal between CSPi's ARIA Cybersecurity Solutions and a top pharmaceutical company is a significant event with potential financial implications. For CSPi, this deal represents a substantial revenue opportunity and may positively influence investor perceptions, potentially leading to an uptick in stock value. The size and profile of the client—a Fortune-500 company—further enhance the credibility of CSPi's product offering in the market.
From an investment standpoint, the ability of AZT PROTECT to prevent costly cyberattacks could translate into operational cost savings for the pharmaceutical company, preserving their bottom line. In light of the recent high-profile cyberattacks, such as SolarWinds, investors are increasingly aware of the financial and reputational risks associated with cybersecurity breaches. Consequently, companies that proactively invest in robust cybersecurity solutions may be viewed as more resilient and attractive to investors.
The deal also highlights the growing importance of cybersecurity in the valuation of companies, especially in sectors with high regulatory scrutiny and critical public health impact, such as pharmaceuticals. The market may respond favorably to companies that demonstrate a commitment to protecting their critical infrastructure, which in turn can lead to enhanced long-term shareholder value.
From a risk management perspective, the adoption of AZT PROTECT by a major pharmaceutical company represents a strategic move to mitigate the risks posed by cyber threats to operational technology. The pharmaceutical industry is inherently high-risk due to its stringent regulatory environment and the potential impact of disruptions on public health. The consequences of a successful cyberattack extend beyond immediate financial losses to include regulatory penalties, reputational damage and the potential for compromised patient safety.
The proactive stance of deploying a solution like AZT PROTECT can be seen as a form of risk transfer, where the cost of the cybersecurity solution is weighed against the potential costs of a cyberattack. By investing in a solution that is designed to thwart advanced zero-day and supply chain attacks, the pharmaceutical company is effectively reducing its exposure to a growing category of risks.
Furthermore, the patented AI-driven technology behind AZT PROTECT could represent a competitive advantage in terms of risk management, as it offers a more adaptive and responsive defense mechanism compared to traditional cybersecurity solutions. This investment in cutting-edge technology may be indicative of a larger trend in risk management strategies, placing a premium on innovation to stay ahead of evolving threats.
Top 5 pharmaceutical in a multi-million dollar deal deploys AZT PROTECT to protect critical assets from cyberattack
BOSTON, MA / ACCESSWIRE / February 12, 2024 / ARIA Cybersecurity Solutions, a CSPi business (NASDAQ:CSPi), announced today that one of the world's largest pharmaceutical manufacturers has selected ARIA Cybersecurity's AZT PROTECT™ solution to protect its critical infrastructure from a new wave of sophisticated cyberattack. The US-based multinational corporation, a Fortune-500 company with billions of dollars in annual revenue, in a multi-million dollar deal will deploy AZT PROTECT across its global manufacturing, protecting over 40 facilities in response to the growing cybersecurity threat to operational technology (OT) from hostile nation states, terrorism, and organized cybercrime.
AZT PROTECT is the first-of-its-kind solution developed to protect OT environments from attacks such as those inflicted on Merck, WestRock, Clorox, and the SolarWinds attacks that impacted thousands of companies across its supply chain. The pharmaceutical industry is particularly vulnerable to sophisticated cyberattacks that are proven to bypass existing cyber defenses. Such an attack on the industry would have far-reaching financial, reputational, and regulatory consequences, and could even impact patient access to important medicines.
Unlike leading next-generation antivirus (NGAV) and endpoint detection response (EDR) solutions, AZT PROTECT is custom-built for OT environments, offering protection against the most advanced zero-day and supply chain attacks, without the need for continuous cloud updates resulting in weekly production downtime interruptions to apply updates and patches. AZT PROTECT neutralizes attacks in real time as they try and execute in device memory, stopping the attacks before they cause harm. It leverages a patented AI-driven technique to continuously analyze executable code, scripts, and processes.
To learn more about how AZT PROTECT protects pharmaceutical manufacturers, please watch our latest webinar at: https://info.ariacybersecurity.com/webinar-safeguard-ot-environments
Launched in July 2023, AZT PROTECT is being deployed in industrial settings that use OT to manage physical infrastructure supporting functions such as R&D, manufacturing, and distribution. A major Fortune-500 chemical manufacturer recently rolled out AZT PROTECT to protect its critical production applications. The solution is also being deployed by a major western intelligence agency to protect its critical intelligence gathering and analysis operations from cyberattack. [WA1]
"A cyberattack on a pharmaceutical's facility could lead to theft of intellectual property, compromised safety and quality, regulatory fines, and major disruption to manufacturing processes. And yet many companies in the industry are ill-prepared to protect their critical assets from a new wave of cyberthreat that can bypass network-based protections and modern cloud-based NGAV solutions," says Gary Southwell, General Manager of ARIA Cybersecurity. "This new contract with one of the world's largest pharmaceutical companies to deploy AZT PROTECT is another endorsement for our breakthrough approach to OT cybersecurity that protects critical production environments from all forms of attack, including those never seen before."
ABOUT ARIA CYBERSECURITY SOLUTIONS
ARIA Cybersecurity Solutions, a business of CSPi Inc., recognizes that better, stronger, more effective cybersecurity starts with a smarter approach. Our solutions provide new ways for organizations to protect their most critical assets-they can shield their critical applications from attack with our AZT solution, while monitoring internal traffic, device-level logs, and alert output with our ARIA ADR solution to substantially improve threat detection and surgically disrupt cyberattacks and data exfiltration. Customers in a range of industries rely on our solutions to accelerate incident response, automate breach detection, and protect their most critical assets and applications-no matter where they are stored, used, or accessed. Learn more at ARIACybersecurity.com.
CONTACT:
ARIA Cybersecurity Media Contact
Gary Southwell
info@ariacybersecurity.com
SOURCE: CSP Inc.
View the original press release on accesswire.com
FAQ
What solution has the pharmaceutical manufacturer selected to protect its critical infrastructure from cyberattacks?
How many facilities will be protected by AZT PROTECT?
What type of attacks is AZT PROTECT designed to defend against?
What sets AZT PROTECT apart from leading NGAV and EDR solutions?
How does AZT PROTECT neutralize attacks in real time?
